[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-device-QAZ":3},{"classification":4,"mappedDevices":35,"similarCandidates":36,"relatedClassifications":117,"syncDates":118,"translation":125,"marketSummary":132,"recalls":148,"k510s":150,"pmas":169},{"id":5,"product_code":6,"device_name":7,"device_class":8,"regulation_number":9,"medical_specialty":10,"medical_specialty_description":11,"review_panel":12,"submission_type_id":13,"definition":14,"implant_flag":15,"life_sustain_support_flag":15,"gmp_exempt_flag":15,"raw":16,"created_at":29,"updated_at":30,"recall_count":31,"latest_recall_date":32,"k510_count":33,"pma_count":31,"event_count":34},6172,"QAZ","Cancer Predisposition Risk Assessment System","2","866.6090","MG","Medical Genetics","PA","1","A qualitative in vitro molecular diagnostic system used for the detection of select variants in specified cancer-related genes. The device is intended to be used on genomic DNA isolated from human specimens collected by the user. The results of the test provide users with a genetic health risk assessment for developing certain cancers. The test may not include all variants associated with a predisposition of developing cancer and is not intended to describe a person’s overall risk of developing any type of cancer nor to aid in determination of treatment or act as a substitute for recommended cancer screenings or appropriate follow-up. The device is for over-the-counter use.",false,{"openfda":17,"definition":14,"device_name":7,"review_code":26,"device_class":8,"implant_flag":27,"product_code":6,"review_panel":12,"gmp_exempt_flag":27,"third_party_flag":27,"medical_specialty":10,"regulation_number":9,"submission_type_id":13,"unclassified_reason":26,"life_sustain_support_flag":27,"medical_specialty_description":11,"summary_malfunction_reporting":28},{"k_number":18,"fei_number":23,"registration_number":25},[19,20,21,22],"K211499","K182784","K223597","DEN170046",[24],"3007699459",[24],"","N","Ineligible","2026-08-18T05:52:53.233452+00:00","2026-08-24T02:00:48.493322+00:00",0,null,4,2,[],[37,46,55,64,72,79,87,94,102,109],{"medical_device_id":38,"generic_name":39,"class_classification":40,"jmdn_code":41,"name_similarity":42,"definition_similarity":43,"vector_similarity":44,"score":45},1157,"遺伝子変異解析システム（がんゲノムプロファイリング検査用）","Ⅲ","60943033",0.204819,0.229885,0.760342,0.0310993,{"medical_device_id":47,"generic_name":48,"class_classification":49,"jmdn_code":50,"name_similarity":51,"definition_similarity":52,"vector_similarity":53,"score":54},1356,"汎用画像診断装置ワークステーション","Ⅱ","70030000",0.157895,0.292308,0.637027,0.0223471,{"medical_device_id":56,"generic_name":57,"class_classification":58,"jmdn_code":59,"name_similarity":60,"definition_similarity":61,"vector_similarity":62,"score":63},3840,"吸引器用キャニスタ","Ⅰ","34858000",0.245614,0.245243,0.511639,0.0163934,{"medical_device_id":65,"generic_name":66,"class_classification":40,"jmdn_code":67,"name_similarity":68,"definition_similarity":69,"vector_similarity":70,"score":71},1140,"体細胞遺伝子変異解析システム（抗悪性腫瘍薬適応判定用）","71059003",0.110169,0.245033,0.752493,0.016129,{"medical_device_id":73,"generic_name":74,"class_classification":49,"jmdn_code":75,"name_similarity":76,"definition_similarity":77,"vector_similarity":78,"score":71},1288,"X線CT組合せ型ポジトロンCT装置","70010010",0.21875,0.267857,0.610095,{"medical_device_id":80,"generic_name":81,"class_classification":40,"jmdn_code":82,"name_similarity":83,"definition_similarity":84,"vector_similarity":85,"score":86},1165,"体細胞遺伝子変異解析セット（抗悪性腫瘍薬適応判定用）","71059023",0.0578512,0.208333,0.729022,0.015873,{"medical_device_id":88,"generic_name":89,"class_classification":49,"jmdn_code":90,"name_similarity":91,"definition_similarity":92,"vector_similarity":93,"score":86},2359,"肝臓保存・搬送装置","42919000",0.227273,0.19457,0.562199,{"medical_device_id":95,"generic_name":96,"class_classification":40,"jmdn_code":97,"name_similarity":98,"definition_similarity":99,"vector_similarity":100,"score":101},1147,"遺伝子変異解析セット（がんゲノムプロファイリング検査用）","60943013",0.127907,0.194103,0.713996,0.015625,{"medical_device_id":103,"generic_name":104,"class_classification":49,"jmdn_code":105,"name_similarity":106,"definition_similarity":107,"vector_similarity":108,"score":101},3001,"MR組合せ型ポジトロンCT装置","58250002",0.206349,0.26945,0.585822,{"medical_device_id":110,"generic_name":111,"class_classification":40,"jmdn_code":112,"name_similarity":113,"definition_similarity":114,"vector_similarity":115,"score":116},1153,"体細胞遺伝子変異解析プログラム（抗悪性腫瘍薬適応判定用）","70159013",0.056,0.214612,0.709271,0.0153846,[],{"510k":119,"classification":120,"enforcement":121,"event":122,"pma":123,"warning_letter":124},"2026-08-24T02:00:50.297+00:00","2026-08-24T02:00:49.319+00:00","2026-08-24T02:00:50.059+00:00","2026-08-24T04:00:49.186+00:00","2026-08-24T02:00:50.609+00:00","2026-08-20T03:28:02.95+00:00",{"product_code":6,"device_name_ja":126,"definition_ja":127,"commentary_ja":128,"model_name":129,"source_hash":130,"reviewed_by":32,"reviewed_at":32,"created_at":131,"updated_at":131},"がん罹患性遺伝的リスク評価システム","本品は、特定のがん関連遺伝子における選択された変異の検出に用いられる定性的なインビトロ分子診断システムである。本品は、使用者が採取したヒト検体から単離されたゲノムDNAに対して使用することを意図している。本検査の結果は、使用者に対して特定のがんを発症する遺伝的健康リスクの評価を提供する。本検査は、がん罹患性に関連する全ての変異を網羅するものではなく、ある人の全体的ながん発症リスクを説明すること、治療の決定を補助すること、又は推奨されるがん検診若しくは適切な経過観察の代替となることを意図したものではない。本品は一般用（OTC）として使用されるものである。","本機器はクラスIIに分類され、510(k)（市販前届出）による審査区分が適用されます。これは、市販前に既存の同等な機器との実質的同等性を示すことで承認申請が可能な区分であり、クラスIIIに適用される市販前承認（PMA）に比べて審査要件が相対的に簡略化されています。","claude-sonnet-5","2bd0f43d4f3f2d4a5b090188c7fffa11593619616f2b1f6f9d5da414e984da90","2026-08-24T02:35:22.423427+00:00",{"product_code":6,"summary_ja":133,"stats":134,"stats_hash":146,"model_name":129,"created_at":147,"updated_at":147},"510(k)は累計4件で、参入企業数は1社、直近5年では2件、最新の判定は2023年8月です。PMAの実績は確認されていません。不具合報告は累計2件で、いずれも傷害（Injury）に関するものであり、死亡や不具合（Malfunction）の報告は確認されておらず、主な問題は「デバイス使用に関する問題（Use of Device Problem）」です。回収の実績は確認されていません。",{"pma":135,"k510":136,"as_of":139,"events":140,"recalls":142,"top_problems":144},{"latest":32,"originals":31,"supplements":31},{"total":33,"last5y":34,"latest":137,"applicants":138},"2023-08-31",1,"2026-08",{"death":31,"other":31,"total":34,"injury":34,"last5y":34,"malfunction":31,"latest_month":141},"2024-07",{"total":31,"last5y":31,"latest":32,"class_i":31,"class_ii":31,"class_iii":31,"top_root_causes":143},[],[145],"Use of Device Problem","f56741adfccf9f9db334440d8aa4cdcfe5fc1def296251f0c07ad527752b1276","2026-08-24T05:15:00.389328+00:00",{"items":149,"total":31},[],{"items":151,"total":33},[152,158,161,164],{"k_number":21,"device_name":153,"applicant":154,"decision_date":137,"clearance_type":155,"decision_code":156,"statement_or_summary":157},"23andMe® Personal Genome Service® (PGS®) Genetic Health Risk Report for BRCA1\u002FBRCA2 (Selected Variants)","23AndMe, Inc.","Traditional","SESE","Summary",{"k_number":19,"device_name":159,"applicant":154,"decision_date":160,"clearance_type":155,"decision_code":156,"statement_or_summary":157},"23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)","2022-01-06",{"k_number":20,"device_name":162,"applicant":154,"decision_date":163,"clearance_type":155,"decision_code":156,"statement_or_summary":157},"MUTYH-Associated Polyposis (MAP)","2019-01-18",{"k_number":22,"device_name":165,"applicant":154,"decision_date":166,"clearance_type":167,"decision_code":168,"statement_or_summary":32},"23andMe PGS Genetic Health Risk Report for BRCA1\u002FBRCA2 (Selected Variants)","2018-03-06","Direct","DENG",{"items":170,"total":31},[]]